//
Treatment and prevention of lipoprotein(a)-mediated cardiovascular disease: the emerging potential of RNA interference therapeutics
Long-term effects of intensive glucose lowering on cardiovascular outcomes
Sox17 Controls Emergence and Remodeling of Nestin-Expressing Coronary Vessels
Independent Association of Lipoprotein(a) and Coronary Artery Calcification With Atherosclerotic Cardiovascular Risk
2019 Guidelines on Diabetes, Pre-Diabetes and Cardiovascular Diseases developed in collaboration with the EASD ESC Clinical Practice Guidelines
Cardiovascular risk prediction in type 2 diabetes: a comparison of 22 risk scores in primary care settings
Active factor XI is associated with the risk of cardiovascular events in stable coronary artery disease patients
International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) trial: Rationale and design